Staying Informed

Opexa Therapeutics’ Therapy for Multiple Sclerosis Featured in FOX Television News Story

Opexa Therapeutics, Inc. , a biotechnology company developing Tcelna®, a novel T-cell immunotherapy for the treatment of multiple sclerosis , is pleased to announce that Tcelna has been featured in a FOX Atlanta Channel 5 Newscast titled “New Therapy Could Battle Autoimmune Diseases.” The story by FOX Medical Team reporter Beth Galvin highlights Opexa’s ongoing Phase IIb clinical trial in ...

 

This post is a mere snippet of world-wide industry news, sponsored by:
BizLocal.com and BizLocalForSale.com
BizLocal(tm) is a brand and web-property of Inspetta LLC, providing innovative web, software and marketing services to business.  Call 888-221-0106 for more information.

Comments
Only registered users can leave comments.
Comment text: